Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Binzhou Zhiyuan Biotechnology is a specialized high-tech enterprise focused on the research, development, and production of cyclodextrin derivatives and inclusion complexes. As a leading manufacturer of pharmaceutical excipients in China, the company provides critical components such as Hydroxypropyl Betadex and Sulfobutyl Ether Beta Cyclodextrin Sodium, which are used to improve the solubility and stability of active pharmaceutical ingredients. Zhiyuan Biotechnology operates state-of-the-art GMP-compliant facilities and maintains Drug Master Files (DMF) with both the US FDA and China's NMPA. Their products serve a wide range of industries, including pharmaceuticals, food, cosmetics, and environmental protection. The company is recognized for its robust R&D capabilities and its role as a key supplier in the global drug delivery supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhiyuan Biotechnology.